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Arterialwall dynamics arise from the synergyof passivemechano-elastic prop-
erties of the vascular tissue and the active contractile behaviour of smooth
muscle cells (SMCs) that form the media layer of vessels. We have developed
acomputational framework that incorporatesboth these components toaccount
for vascular responses to mechanical and pharmacological stimuli. To validate
the proposed framework and demonstrate its potential for testing hypotheses
on the pathogenesis of vascular disease, we have employed a number of
pharmacological probes that modulate the arterial wall contractile machinery
by selectively inhibiting a range of intracellular signalling pathways. Exper-
imental probes used on ring segments from the rabbit central ear artery are:
phenylephrine, a selectivea1-adrenergic receptoragonist that induces vasocon-
striction; cyclopiazonic acid (CPA), a specific inhibitor of sarcoplasmic/
endoplasmic reticulumCa2þ-ATPase; and ryanodine, a diterpenoid thatmodu-
lates Ca2þ release from the sarcoplasmic reticulum. These interventions were
able todelineate the roleofmembraneversus intracellular signalling,previously
identified as main factors in smooth muscle contraction and the generation of
vessel tone. Each SMC was modelled by a system of nonlinear differential
equations that account for intracellular ionic signalling, and in particular Ca2þ
dynamics. Cytosolic Ca2þ concentrations formed the catalytic input to a
cross-bridge kineticsmodel. Contractile output from these cellular components
forms the input to the finite-element model of the arterial rings under isometric
conditions that reproduces the experimental conditions. The model does not
account for the role of the endothelium, as the nitric oxide production was sup-
pressed by the action of L-NAME, and also due to the absence of shear stress on
the arterial ring, as the experimental set-up did not involve flow. Simulations
generated by the integrated model closely matched experimental observations
qualitatively, as well as quantitatively within a range of physiological para-
metric values. The model also illustrated how increased intercellular coupling
led to smooth muscle coordination and the genesis of vascular tone.1. Introduction
The arterial wall can be viewed as a control system able to regulate blood flow in
order to satisfy local tissue oxygenation and nutrition requirements. This function
is performed, in part, by spontaneous fluctuations in vascular tone and diameter,
known as vasomotion, and is facilitated by the contractile apparatus located
within the smooth muscle layer of the arterial wall [1]. Arteries form an anisotro-
pic structure composed of three primary layers that perform distinct functions.
The outermost layer, adventitia, is made of a tissue with fibre dispersion which
confines the inner arterial structures. Active vascular contractility is governed
by the smooth muscle cells (SMCs) located in the second layer, called media.
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of the blood vessels, operates as an active interface between the
blood flow and the medial layer. Between these structures lie
layers of artery-specific connective tissue called elastic lami-
nae [2], which largely convey the mechano-elastic properties
of the vascular wall. The active contractile machinery of
SMCs, driven by the phosphorylation of the actin–myosin
motors, is catalysed by intracellular Ca2þ. Under physiological
conditions the intracellular Ca2þ concentration exhibits modest
variations, however, when operative conditions deviate far
from normal, such as in the case of injury or under pharmaco-
logical interventions, significant fluctuations in intracellular
Ca2þ concentrations may occur that are reflected in the pro-
nounced dynamical variation in vascular tone [3–5]. The
complex structure and function of the arterial wall, even in
the absence of blood flow, suggest that a mathematical/com-
putational multi-physics approach is necessary in order to
elucidate the dynamical intricacy of the underlying biological
system and to address questions that so far evade experimental
investigations. To address this problem, a considerable number
of multiscale/multi-component models for the arterial wall
have been proposed in recent years [6–9]. The development
of models accounting for the elastic behaviour of the vascular
wall has been based on extensive experimentation on the
mechanical properties of vascular tissue under a variety of
stress–strain conditions [10–14]. Based on these findings,
several methodologies have been proposed in the last decade
for simulating the smooth muscle contractility [15–20].
In spite of considerable advances, the active component of
vascular contractility, centred on the cellular Ca2þ dynamics
of the smoothmuscle has not been incorporated in a systematic
way. This is particularly important as, according to classifi-
cation by Fischer [21], the smooth muscle responsible for
arterial vasomotion can be considered of the ‘fast type’ from
amechano-elastic point of view, and is therefore markedly sen-
sitive to the cellular wall dynamics. Detailed modelling of
vasomotion as an expression of multi-channel ionic signalling
that regulates arterial smooth muscle Ca2þ dynamics, has been
proposed in [22,23]. This work was extensively validated
against a broad range of pharmacological interventions that
specifically inhibit individual transportmechanisms. Extended
cellular arrays of coupled SMCs were subsequently used to
study the emergence of large-scale synchronization [24]. In
this work, we have employed a hybrid model, based
on [22,23], to integrate the active contractile behaviour of the
media smooth muscle layer with the structural response of
the arterial wall. The computational model developed incor-
porates two distinct scales: the cellular, where cytosolic Ca2þ
catalyses cross-bridge (CB) kinetics, and the continuous
where the contractile units (CUs), and therefore the arterial
tissue, exhibit deformation and stress. Evaluation of the CBkin-
etics at cellular level relies on a modified version of the Hai &
Murphy model [25,26]. The cellular network finite-element
design follows the anatomical morphology of the tissue
considered. For the mechano-elastic characterization of the
arterial wall, we follow the work of [17,19,20]. From the
structural point of view, the tissue is assumed to be a fibre-
reinforced hyper-elastic material [11,27] and incompressibility
is enforced bymeans of a standard penaltymethod. Simulation
results were validated against experimental recordings of
vascular tone obtained from rabbit ear arteries under isometric
conditions. In the absence of fluid flow, the relationship
between stress and deformation of the vascular structurebecomes the only stress/deformation-generator mechanism.
In addition, we were able to minimize the influence of the
endothelium on the smooth muscle contractile apparatus by
inhibiting production of nitric oxide (NO), the dominant endo-
thelial control mechanism in the central rabbit ear artery [28].
The performance of the modelling framework has been
tested against a number of cellular Ca2þ dynamics scenarios,
induced by drug interventions able to specifically modulate
the SMCs contractile machinery.2. Modelling methodology
The multiscale modelling methodology that accounts for
the contractile dynamics of the arterial wall is presented in
figure 1, where the flow of information is highlighted.
The model developed is based on the coupling of the
smooth-muscle contractile apparatus with the mechano-
elastic properties of the arterial wall. We outline here the
mathematical formulation of the model components and
their interface as a requirement for emergent coupled behav-
iour. At the cellular level, Ca2þ dynamics is described by a
system of three coupled nonlinear ordinary differential
equations which express cytosolic Ca2þ concentration (x),
Ca2þ concentration within the sarcoplasmic reticulum (SR)
(z) and the membrane potential (h). Physiological regulation
of these variables is due to the coordinated effect of multiple
ionic currents that have been incorporated in the formulation
of the model and are described in detail in the following
section. Cytosolic Ca2þ is the primary catalyst for the phos-
phorylation of CB formation that occurs within each SMC,
and which facilitates the contractile response of the cellular
cytoskeleton. At the level of the CU, four distinct states can
represent the CB kinetics: dephosphorylated myosin (nM),
phosphorylated myosin (nMp), attached actin–myosin fila-
ments (nAM) and attached phosphorylated actin–myosin
filaments (nAMp). The model assumes a spatial uniformity
of CB within the cytosol. The state describing the fractions
of attached actin–myosin filaments (represented as nAMþ
nAMp), along with variable l that describes the physical
deformation of the contractile elements (the stretch ratio in
the tissue structure model), serve as inputs to the CU
model, where the active free energy function is computed.
The calculations performed in the CU model depend on the
internal variable ufs, which represents the current relative
sliding between the filaments. The derivatives of the active
free energy function with respect to the fourth invariant
(@ Ca=@I4, @2 Ca=@I
2
4), calculated at the CU subsystem, are
then passed directly to the tissue structural mechanics
model (with displacement u and pressure p as variables),
where the total (passive and active) tissue stress and defor-
mation is evaluated. This accounts for the arterial wall
structural response. Several stages of this physiological pro-
cess may be probed through targeted pharmacological
interventions (e.g. specific ion channel blockers) to reproduce
and investigate the origin of vascular disease states. All the
model parameters are listed in tables 1, 2 and 4.2.1. Cellular level
2.1.1. Cytosolic Ca2þ homeostasis
The fundamental processes involved in the regulation of
cytosolic Ca2þ concentrations are outlined in figure 2.
cellular level continuous level
Ca2+ dynamics
(c, z, h)
cross-bridges
kinetics
(nAM, nAMp, nMp)
tissue
structure
(u, p)
ln
(nAM, nAMp)n+1
cn+1
n+1
,
∂Ya ∂
2Ya
∂ I4 ∂ I4
2
potential
pharmacological
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response
contractile
unit chemo-
mechanics
(ufs, l)
Figure 1. Levels and subsystems of the media multiscale model. Thin arrows indicate quantities transmitted between the subsystems. Variables in the boxes are
internal variables of the subsystems. Thick arrows represent the input and output of the model. (Online version in colour.)
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incorporated in a model that combines the approaches pre-
viously proposed in [22,23]. In particular, we employed a
system of three ordinary differential equations, as in [23],
but maintained the predominance of ryanodine-sensitive
over InsP3-sensitive intracellular stores, as appropriate for
the rabbit ear arteries used in the experimental study [22].
Moreover, the model constructed maintains the well-
established view that smooth muscle Ca2þ dynamics are
due to the interplay of a membrane and an intracellular oscil-
lator [30]. The mechanism underlying the intracellular Ca2þ
oscillator is Ca2þ induced-Ca2þ release (CICR) via the
ryanodine receptor. Once released into the cytosol, Ca2þ is
re-sequestered by the stores through the sarcoplasmic/
endoplasmic reticulum ATPase (SERCA), thus completing
the cycle. By contrast, the membrane oscillator is centred on
cellular polarization and voltage-operated Ca2þ channels
(VOCCs). Membrane potential is mainly influenced by the
balance between Kþ and Cl2 gradients, and by Naþ-Ca2þ
exchange (NCX), depending on whether the exchanger oper-
ates in forward or reverse mode. The current model also
includes the store operated Ca2þ channel (SOCC), which
links directly store content with cytosolic Ca2þ influx [31].
This addition allows for testing theoretically the role of this
channel in specific pharmacological intervention scenarios.
An explicit delineation of the modelling components is
presented below.
2.1.1.1. Ionic channels
The extracellular influx is the sum of the concentration
currents FA, FS, FV and FN, which represent the Ca
2þ per-
meable non-selective cation channels (NSCC), SOCC,
voltage-operated cation channels (VOCC) and reverse mode
Naþ-Ca2þ exchange (NCX), respectively. In this study, thefirst current is assumed to be constant, while the others
depends on x and h via the following equations:
FS(z) ¼ AS(zS  z), ð2:1Þ
FV(h) ¼ ECa h zCa11þ exp ((h zCa1)=RCa)
 
ð2:2Þ
and FN(x,h) ¼ ENCX x
xþ xNCX (h zNCX)
 
, ð2:3Þ
where AS, zS, ECa, zCa1, RCa, ENCX, xNCX and zNCX are cellular
model parameters. The SR acts as an inner store, uptaking
cytosolic Ca2þ by means of the SERCA pump (FB(x)) and
releasing it into the cytosol through ryanodine-sensitive
SR-Ca2þ release channel (FC(x, z)). Store leakage (FL(x, z))
is also accounted for. These fluxes are described through
the following expressions:
FB(x) ¼ BSR (x)
nSR
(x)nSR þ (xSR)nSR
 
, ð2:4Þ
FC(x,z) ¼ CRy x
pRy
xpRy þ (xRy)pRy
(z)mRy
(z)mRy þ (yRy)mRy
" #
ð2:5Þ
and FL(z) ¼ LSRz, ð2:6Þ
where BSR, nSR, xSR, CRy, pRy, mRy, xRy, yRy and LSR are cellular
model constants. The Ca2þ extrusion from the cytosol by
ATPase pump (FD(x, h)) is modelled as follows:
FD(x,h) ¼ DEX(x)kEx 1þ h zExREx
 
, ð2:7Þ
where DEX, kEX, zEX and REX are cellular model parameters.
The chloride (FCl(x, h)) and potassium (FK(x, h)) ion
membrane fluxes are modelled as follows:
FCl(x,h) ¼ ECl x
xþ xCl
(h zCl)
 
ð2:8Þ
Table 1. Table of parameters: Ca2þ dynamics and cross-bridges (CB)
kinetics. Parametric values associated with Ca2þ dynamics are taken from
Boileau et al. [29], while parameters for CB kinetics are from Parthimos
et al. [22].
parameter description value
Ca2þ dynamics
FA Ca
2þ inﬂux via NSCC 0.6 (mM s21)
LSR SR leak rate constant 0.025 (s
21)
g scaling factor 1.0 (V mM21)
AS SOCC parameter 0.0 (s
21)
zS SOCC parameter 4.0 (mM )
ECa VOCC inﬂux cell conductance 12.0 (mM (V s)
21)
zCa1 VOCC inﬂux reversal
potential
0.13 (V)
zCa2 VOCC inﬂux half-point of
activation sigmoid
20.024 (V)
RCa VOCC inﬂux max. slope of
activation sigmoid
0.0085 (V)
ENCX NCX cell conductance 43.8 (mM (V s)
21)
zNCX NCX reversal potential 20.04 (V)
xNCX NCX half-point of
Ca2þactivation
0.5 (mM)
BSR SR uptake rate 400.0 (mM s
21)
xSR SR uptake half-point of
ATPase activation sigmoid
4.4 (mM)
nSR SR uptake Hill coefﬁcient 2 (2)
CRy RyR CICR rate 1250.0 (mM s
21)
yRy RyR CICR half-point of Ca
2þ
efﬂux sigmoid
8.9 (mM)
xRy RyR CICR half-point of CICR
activation sigmoid
0.9 (mM)
mRy RyR CICR Hill coefﬁcient 2 (2)
pRy RyR CICR Hill coefﬁcient 4 (2)
DEX Ca
2þ extrusion by ATPase
pump rate
6.25 (mM s2 1)
zEx Ca
2þ extrusion by ATPase
pump constant
20.1 (V)
REx Ca
2þ extrusion by ATPase
pump constant
0.25 (V)
kEx Ca
2þ extrusion by ATPase
pump constant
2
ECl Cl
2 channels cell
conductance
65.0 (mM (V s)21)
zCl Cl
2 channels reverse
potential
20.025 (V)
xCl Cl
2 channels Ca2þ
sensitivity
0.0 (mM)
EK K
þ efﬂux cell conductance 43.0 (mM s21)
(Continued.)
Table 1. (Continued.)
parameter description value
zK K
þ efﬂux reverse potential 20.095 (V)
zCa3 K
þ efﬂux half-point of
activation sigmoid
20.027 (V)
RK K
þ efﬂux max. slope of KCa
activation sigmoid
0.012 (V)
bK K
þ efﬂux Ca2þ sensitivity
of KCa channel activation
sigmoid
0.0 (mM)
aC cellular Ca
2þ diffusivity 1.0 (s21)
aV cellular voltage diffusivity 1.0 (s
21)
CB kinetics
t0 kinetic model ﬁtting
parameter
1.7 (s21)
t2 kinetic rate 0.5 (s
21)
t3 kinetic rate 0.4 (s
21)
t4 kinetic rate 0.1 (s
21)
t5 kinetic rate 1.0 (s
21)
x0 kinetic saturation constant 0.6 (mM)
u enhancement kinetics
coefﬁcient
1.0 (2)
Table 2. Table of parameters: contractile units mechanics and tissue
structure. All parametric values reported in the table are from Murtada &
Holzapfel [20].
parameter description value
CU mechanics
aa material parameter 26.68 (kPa)
ba material parameter 0.00833
(s21)
kAMp parameter related to the force of a
power-stroke of a single CB
203.71 (kPa)
kAM parameter related to the force-
bearing capacity of a
dephosphorylated CB during
muscle extension
61.14 (kPa)
uoptfs material parameter 0.48 (2)
x0 material parameter 0.4255 (2)
tissue structure
k bulk modulus 4.0 (kPa)
ma active shear modulus 5301.0 (kPa)
mp passive shear modulus 0.84 (kPa)
cp1 material parameters 3.15 (kPa)
cp2 material parameter 0.035 (2)
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NSCC VOCC NCX SOCC
CICR
SERCA
sarcoplasmic
reticulum
CI–,K+ Ca2+
Ca2+
Ca2+
Vm
Figure 2. Cellular Ca2þ model illustrating the membrane and intracellular
components. (Online version in colour.)
nM
t1
t1
t5 t4 t3
t2
t2
nMP
nAMPnAM
Figure 3. Four states of the actin–myosin cross-bridges kinetics. Each arrow
represents a transition between two states and is associated with a specific
kinetic rate. The arrows indicate the direction of the transitions.
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FK(x,h) ¼ EK (h zK) x
xþ bK exp ((h zK)=RK)
 
, ð2:9Þ
where ECl, xCl, zCl, EK, zK, bK and RK are cellular model
constants.2.1.1.2. Intercellular communication
In a cellular cluster, each cell is able to communicate with its
neighbours by exchanging Ca2þ ion (JCa) and voltage (JV)
currents. Assuming that the cellular size (ratio between the
volume and surface) is uniform along the grid, we can
define the net fluxes JCa,i and JV,i exchanged by the ith cell
as follows:
JCa,i ¼ aCa
XnNeigh
j¼1
(xi  xj) ð2:10Þ
and
JV,i ¼ aV
XnNeigh
j¼1
(hi  hj), ð2:11Þ
where nNeigh is the number of adjacent elements, and aCa
and aV are the intercellular diffusion coefficients.
2.1.1.3. Global cellular balance
The system variables x, z and h evolve in time according to
the following system of nonlinear ordinary differential
equations:
_x ¼ FA þFS(z)FV(h)þFN(x,h)FB(x)þFC(x, z)
FD(x,h)þFL(z)þ JCa,i ð2:12Þ
_z ¼ FB(x)FC(x,z) ð2:13Þ
and _h ¼ g(FCl(x,h) 2FV(h)FN(x,h)FK(x,h))þ JV,i,
ð2:14Þwhere g is a scaling factor relating the net movement of ion
fluxes to the membrane potential.
2.1.2. Cross-bridges kinetics
The kinetics is described through four different states
representing the fraction of CB that are: (i) attached and
dephosphorylated (nAM), (ii) attached and phosphorylated
(nAMp), (iii) detached and dephosphorylated (nA) and
(iv) detached and phosphorylated (nAp). The temporal
evolution of the four-state kinetics shown in figure 3 is
described through the following system of ordinary
differential equations:
_nM ¼ t1nM þ t2nMp þ t5nAM ð2:15Þ
_nMp ¼ t1nM  (t2 þ t3)nMp þ t4nAMp ð2:16Þ
_nAMp ¼ t3nMp  (t2 þ t4)nAMp þ t1nAM ð2:17Þ
and _nAM ¼ t2nAMp  (t1 þ t5)nAM, ð2:18Þ
where t1, t2, t3, t4 and t5 are the kinetic rates. Among these, t1,
depends on the intracellular Ca2þ concentration (x) via [22]:
t1 ¼ t0 x
2
x2 þ x02
 
, ð2:19Þ
where t0 and x0 are the material constants. As nM þ nMp þ
nAMp þ nAM¼1, one of the states (nM in this work) can be
assumed dependent on the other three states, leading to a
three independent variables system.
2.2. Continuous-level model
2.2.1. Contractile unit mechanics
To model the force development within the CU, the work
of Murtada et al. [17,19,20] is followed. Both phosphoryla-
ted and de-phosphorylated attached CB (nAMp, nAM) are
considered elastic with the same mechanical stiffness. As
mentioned previously, l, the current stretch of the CU, can
also be defined as the ratio between the current and the refer-
ence CU length. The average elastic elongation of the attached
CB (ucb) can thus be calculated as follows:
ucb ¼ l 1 ufs: ð2:20Þ
We note that both ufs (representing the relative fibre sliding)
and ucb are normalized with respect to the reference CU
length and are taken to be negative for contraction. The rela-
tive actin–myosin filament sliding ufs in the CU can be driven
either by the myosin power-stroke or the external force/
deformation. This internal variable is thus decomposed into
rsif.royalsoc
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fs ) component. The
temporal evolution of the chemical component uchemfs can be
derived from the following force balance:
(Pa þ aa)( _uchemfs þ ba) ¼ ba(Pc þ aa), ð2:21Þwhere Pc is the stress associated with the driving force from
the cross-bridges while ba and aa are fitting parameters.
The internal driving stress Pc depends on the contraction/
relaxation state of the CU, ie,ietypublishing.org
J.R.SoPc ¼
L0kAMpnAMp if Pa , L0kAMpnAMp (contraction state),
L0(kAMpnAMp þ kAMnAM) if Pa . L0(kAMpnAMp þ kAMnAM) (relaxation state),
Pa else (neutral state),
8<
: ð2:22Þc.Interface
15:20170732where kAMp is a parameter related to the force of a power-
stroke of a single CB and kAM is related to the force-bearing
capacity of a dephosphorylated CB during muscle extension.
The energy stored in the CU is related to the filament sliding
resistance from the surrounding matrix (Pa), which can
also be seen as the (averaged) first Piola–Kirchhoff stress over
the CU:
Pa ¼ maL0(nAMp þ nAM)ucb, ð2:23Þ
where ma behaves like an active shear modulus and L0 defines
the relative filament overlap as a parabolic function of ufs:
L0 ¼ ufs 
u2fs
2uoptfs
þ x0
 !
, ð2:24Þ
where uoptfs and x0 are material parameters.2.2.2. Tissue structure
From the structural point of view, the medial tissue is con-
sidered as a hyper-elastic fibre-reinforced material [11,27],
with the fibres aligned along the circumferential direc-
tion [20]. Various representations of the arterial tissue have
been previously proposed, including models of transverse
fibre distribution at a diagonal angle [11,27,32]. These
approaches were specifically proposed to accurately represent
the adventitia layer of the vessel wall. As we are primarily
focusing on the media layer, in this study, we have followed
the work proposed in [20] where the media layer fibres are
aligned only in the circumferential direction. The free
energy function (C) is split into volumetric (Cvol) and isocho-
ric components; the latter is then decomposed into active
( Ca), accounting for the CU chemo-mechanics, and passive
parts ( Cp), i.e.
C ¼ Cvol þ Ca þ Cp: ð2:25Þ
The volumetric part is assumed to be proportional to the
energy potential as
Cvol ¼ k
(J  1)2
2
, ð2:26Þ
where k and J are, respectively, the penalty number and the
determinant of the deformation tensor F (J ¼ det F). Both
Ca and Cp depend on the CU stretch (l), that can also be
related to the fourth invariant as
l ¼
ﬃﬃﬃﬃ
I4
p
¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
a0  Ca0
q
, ð2:27Þ
where C is the deviatoric part of the right Cauchy deformation
tensor and a0 is the direction of the media unstressed fibre.
The active component depends directly on the CB attached(nAMp, nAM), i.e.
Ca ¼ ma
L0
2
(nAMp þ nAM)(ucb)2: ð2:28Þ
The passive part is modelled as a classical anisotropic material
with one fibre aligned with the SMCs as
Cp ¼
mp
2
(I1  3)þ
cp1
2cp2
{exp[cp2(I4  1)2] 1}, ð2:29Þ
where mp, cp1 and cp2 are material constants. More details
regarding the solid mechanics formulation are provided in
electronic supplementary material, S1.
2.3. Multiscale coupling and solution procedure
2.3.1. Space discretization
Each level of the framework is discretized by a spatial grid. The
cellular network grid reflects the morphology of the tissue, so
that each element represents a ‘real’ cell. For the continuous
level, a finite-element discretization of the domain was carried
out. By assigning each SMC to each finite-element the connec-
tivity of the cellular grid and the mesh coincide. The variables
computed at the cellular level (i.e. Ca2þ dynamics and CB
kinetics) may be considered as internal variables in the finite-
element framework. The CU variables (ufs, l, etc.) are
evaluated at the Gauss integration points of the finite-element,
in order to take into account the spatial diversity of deforma-
tion over the element. For the structural problem, staggered
finite-elements are used in which the displacement field is
interpolated linearlywhile the pressure and dilation coefficient
are constant over each element. The nonlinear problem is
solved via a classical Newton–Raphson procedure.
2.3.2. Time integration
The models/subsystems constituting the framework are solved
in a block segregated fashion, as depicted in figure 1. As there
is no feedback between the subsystems, it is possible to
employ a different and optimal time integration strategy for
each of them. Thus, the Ca2þ dynamics is solved by an explicit
and adaptive scheme (Runge–Kutta Merson), whereas the
time-dependent equations for both the CB kinetics and
CU mechanics are solved by the forward Euler method (as
in [20]).Note that for computing theCUmechanics thedeformed
configuration (expressed in terms of l) of the previous time step
is used. By comparison, the tissue mechanics problem is solved
in an implicit manner. The methodology proposed is valid for
either quasi-static or dynamic problems, depending onwhether
the case considered is under isometric or non-isometric con-
ditions. The same time step was employed for all subsystems.
The solution procedure is presented step by step in table 3.
The complete model has been implemented into an in-house
Table 3. Solution procedure for evaluating all the system variables in time.
Cellular level (solving consecutively two linear problems for nAM and
nAMp)
(1) Time initialization t¼0
(2) Loop over the temporal discretization Dt1 points
(3) Loop over the cell framework (the FE mesh in this work)
(4) Compute Ca2þ variables explicitly (Runge–Kutta Merson) from
equations (2.10)– (2.12)
(5) Compute rate constant t1 from equation (2.17)
(6) Compute CB kinetic states explicitly (forward Euler) from
equation (2.13)– (2.16)
(7) Time update t ¼ t þ Dt1
Continuous level (solving a nonlinear problem for u and p)
(1) Time initialization t ¼ 0
(2) Loop over the temporal discretization Dt2 points
(3) Newton–Raphson (NR) algorithm
(4) Loop over the ﬁnite-elements
(5) If it is the ﬁrst NR iteration, then interpolate CB kinetic states in
time from Dt1 to Dt2
(6) Loop over the Gauss integration points
(7) Compute CB mechano-chemical variables, equations (2.18)–
(2.22)
(8) Compute ﬁrst- and second-order derivatives of Ca with respect
to I4
(9) Compute total stress and elasticity tensor
(10) Assemble stiffness matrix and residual vector
(11) Solve linearized system and variables updating
(12) If the residual error condition is satisﬁed, then time update
t ¼ t þ Dt2 and go to 2.
50 µm
800 µm
250 µm
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00
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Figure 4. (a) Size and geometry of the arterial section set in the myograph
through two hooks. (b) Location of cell1, cell2 and cell3 in the three-dimensional
mesh representing one eighth of the ring. (Online version in colour.)
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post-processing analysis. The finite-element mesh has been rea-
lized by means of the three-dimensional mesh generator
software Gmsh [34].(b)
450 µm
750 µm
x
z
Figure 5. Arterial section deformation during the loading phase, initial (a)
and stretched (b) configurations.3. Experimental study
The pharmacological studies employed in the validation of the
modellingmethodologyalongwith themodel set-updeveloped
to reproduce the experimental settings are reported below.
3.1. Experimental protocol
Isolated rabbit ears were obtained as described previously [1],
the central ear artery was removed and cleaned of adherent fat
and connective tissue. Tomeasure force, 2mmwide ringswere
mounted on 0.25mm diameter steel hooks in a myograph
(model 610M, Danish Myotechnology, Aarhus, Denmark)
containing oxygenated (95% O2; 5% CO2) Holman’s buffer
(composition in mM: NaCl 120, KCl 5, NaH2PO4 1.3,
NaHCO3 25, CaCl2 2.5, glucose 11 and sucrose 10) at 37.08C.
Prior to any pharmacological interventions, the rings weremaintained at a resting tension of 1mN over a 60min equili-
bration period, with frequent readjustments in baseline
tension to correct for stress relaxation. The average inner and
outer diameters of the annular segments were approximately
0.7 and 0.8 mm, respectively (figure 4a). Following the loading
aC = 0.0 s–1, aV = 0.0 s–1
aC = 0.1 s–1, aV = 0.1 s–1
aC = 1.0 s–1, aV = 1.0 s–1
cell1
cell2
cell3
c 
(µM
)
0
0.5
1.0
2.0
1.5
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(µM
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0.5
1.0
2.0
1.5
c 
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)
0
0.5
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2.0
1.5
50 100
t (s)
150 200
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Figure 6. Temporal evolution of x at three different cells (labelled cell1, cell2 and cell3) for different aC and aV.
Table 4. Ca2þ dynamics and CB kinetics parameters for simulating the drug interventions. The variation of parameters is carried out linearly.
parameter phenylephrine CPA ryanodine
FA (mM s
21) 0.6 ! 4.2 in Var s 0.8 0.8
BSR (mM s
21) 400 400 ! 200 in 1000 s 400
CRy (mM s
21) 1250 1250 1250 ! 312.5 in 2000 s
AS (s
21) 0.0 0.0 0.1
u 1.0 30.0 0.5
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shown in figure 5. By considering a Cartesian reference
system, the loading is applied along the x-direction. Prep-
arations were incubated for 30min with both the endothelial
nitric oxide synthase inhibitor N(G)-Nitro-L-arginine methyl
ester (L-NAME, 300mM) and the cyclooxygenase inhibitor
indomethacin (10mM) to inhibit prostanoid formation. Rings
were then constricted with phenylephrine (PE, 1mM) and,
once constrictor responses had reached a stable plateau, cumu-
lative concentration–response curves to 10 and 30mM CPA,
and 10 and 30mM ryanodine were obtained.3.2. Model settings
Froma structural point of view, each ring is assumed to deform
symmetricallywith respect to the x-plane,while no translations
along y and in the longitudinal direction (z) are expected.
The system can thus be reduced to one-eighth of the ring. A
finite-element mesh consisting of 5750 linear hexahedralelements is used in the calculations. The global force F applied
to the hooks is evaluated by integrating the traction contri-
bution of the reduced arterial system over the global contact
surface. For the cellular cluster, each cell was associated with
one element. At subcellular level, we associate a CU to each
Gauss integration point. To account for cellular variability
(e.g. size, rates of Ca2þ uptake/extrusion) the term correspond-
ing to the influx via Ca2þ permeable non-selective cation
channels (FA) is randomized with a normal distribution
(mean value given in table 4 for the relevant pharmacological
simulations, and s.d. ¼ 0.1mMs2 1). Randomization ofFA cre-
ates a population of cells exhibiting variable oscillatory
frequency. This allows us to study the effect of increasing
strengths of intercellular coupling as a factor of smooth
muscle synchronization and generation of vascular tone. For
all simulations, the initial values for x, z and h are set equal
to 0.1mM, 0.2mM and 20.02 V, respectively. The reference
set of kinetic rates (t0, t2, t3, t4, t5) necessary for solving the
CB dynamics are taken from Parthimos et al. [22].
c (µM) for t = 0.1 s, aC = 0.1 s–1, aV = 0.1 s–1 
1.600 × 100
1.000 × 10–1
1.225
y
xz
y
xz
y
xz
y
xz
0.85
0.475
1.600 × 100
1.000 × 10–1
1.225
0.85
0.475
1.600 × 100
1.000 × 10–1
1.225
0.85
0.475
1.600 × 100
1.000 × 10–1
1.225
0.85
0.475
c (µM) for t = 0.1 s, aC = 1.0 s–1, aV = 1.0 s–1 
c (µM) for t = 6.0 s, aC = 0.1 s–1, aV = 0.1 s–1 c (µM) for t = 6.0 s, aC = 1.0 s–1, aV = 1.0 s–1 
Figure 7. Temporal evolution of x along the spatial domain for (aC, aV) ¼ 0.1 s21 and (aC, aV) ¼ 1.0 s21. At the top of the figure x is shown at t ¼ 0.1 s for
an weakly coupled cluster of cells (left) and a strongly coupled one (right). At the bottom part the figure x is shown at t ¼ 6.0 s for a weakly coupled cluster of
cells (left) and a strongly coupled one (right). The image has been generated by the Paraview software [33].
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4.1. Cellular coupling conditions
The proposed analysis is carried out for varying levels of cellu-
lar coupling in order to establish the dependency between the
diffusion coefficients aC, aV and the global Ca
2þ dynamics.
These simulations are carried out for an unloaded ring con-
figuration. The variables associated with the Ca2þ dynamics
are monitored for three different cells: cell1, cell2 and cell3
(figure 4b). In figure 6, the time evolution of x for (aC,aV)
equal to 0.0, 0.1, 1.0 s21 is shown. The plot shows clearly that
coupling does not affect significantly the amplitude of x
signal. The cellular coupling tends to synchronize the x beating
pattern along the cluster.
The spatial distribution of x for two coupling levels (weakly
coupled: (aC,aV)¼ 0.1 s21, strongly coupled: (aC, aV)¼ 1.0 s21)
at two different time instants (t¼ 0.1 s, t¼ 6.0 s) are shown in
figure 7. It is evident that coupling promotes the formation of
travelling waves along the annular domain.
4.2. Framework validation
A range of pharmacological interventions associated with the
activation/inhibition of specific cellular mechanisms was
employed for the validation of the model. To mimic the diffu-
sion of pharmacological agents, parametric changes wereapplied in a graded fashion to all the cells constituting the
network. The interventions selected (i.e. phenylephrine,
CPA and ryanodine) are associated with the modulation of
the cellular Ca2þ homeostasis which is reflected in the con-
tractile state of the smooth muscle. The actions of these
pharmacological probes were simulated by the gradual vari-
ations of the associated model parameters, reported in table
4. The actin and myosin filaments are assumed to be
detached for t ¼ 0 s (nM ¼ 0.5 and nMp ¼ 0.5), while the initial
ufs is set equal to 0 for each CU. Cells are assumed to be
strongly coupled with (aC,aV) set equal to 1.0 s
21. The simu-
lated drug interventions were performed only after the Ca2þ
and CB variables reached stationary conditions. For each
plotted result the drug intervention occurred at t ¼ 0 s
unless otherwise stated.
As the ring is clamped at the hooks, the resultant sum
between internal and external forces at the nodes in contact
with the hooks must be null. In this study, we are mainly
interested in the global force developed at the hooks, which
can be seen as the sum of nodal contributions along the con-
tact surface. In addition to this, we compute also the force
developed locally at cell1, which is assumed to be pro-
portional to the sum nAMpþnAM [22]. For a more complete
view of how the contractile force emerges from Ca2þ
dynamics at the cellular level, see electronic supplementary
material, S2.
aC = 0.1 s–1, aV = 0.1 s–1
Dtdil = 50 s
Dtdil = 100 s
aC = 0.1 s–1, aV = 0.1 s–1 
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Figure 8. Time evolution of x and z (cell1) for a simulated phenylephrine intervention. Results are shown for different drug dilution times (Dtdil¼ 50 and 100 s)
and coupling conditions ((aC, aV) ¼ 0.1 s21 and (aC, aV) ¼ 1.0 s21).
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Phenylephrine is a selective agonist of a1-adrenergic recep-
tor, associated with vasoconstriction. The action of
phenylephrine at cellular level was modelled by increasing
the cytosolic Ca2þ influx via NSCCs. A more complete pic-
ture of the action of phenylephrine involves an initial Ca2þ
release from the SR, via inositol 1,4,5-trisphosphate-sensitive
Ca2þ release channels (IP3R channels), followed by sustained
Ca2þ influx into the cytosol through NSCCs. To simulate the
action of phenylephrine, the coefficient FA of each individual
cell was increased by a factor of 7. Therefore, the mean value
of the FA distribution increased from 0.6 to 4.2mMs
21. Two
different drug dilution times (Dtdil ¼ 50 and 100 s) were used,
as shown in figure 8. By increasing cytosolic Ca2þ uptake, x
in cell1 starts to oscillate periodically. This pattern is reflected
also in the store Ca2þ concentration variations (figure 8).
As expected, higher Dtdil involves longer transient before
reaching stationary conditions.
The forces generated by this intervention, normalized with
respect to the force developed at the beginning of the interven-
tion, are presented in figure 9,where three responses are shown
for different dilution times (Dtdil) and different cellular coup-
ling (aC, aV). By comparison to the simulated results, it
appears that the drug was able to activate the muscle tissue
at a dilution time Dtdil  50 s. We also observe that the final
magnitude of the simulated andmeasured force is very similar.4.2.2. Cyclopiazonic acid intervention
Cyclopiazonic acid (CPA) is an inhibitor of the SERCA pump,
preventing refilling of the store and is thus associated with
Ca2þ store depletion. The effect of CPA, in terms ofmodulating
the intracellular Ca2þ oscillator, is highly concentration-dependent as shown previously [35]. CPA was administered
through concentration increases from 10 to 30mM. In a few
experiments CPA concentrations of 100mM were used, which
accelerated the tapering effect already in evidence (see elec-
tronic supplementary material, S2). For simulation purposes,
the action of CPAwas reproduced by linearly decreasing coef-
ficient BSR from 400 to 350mM in 2000 s (while the randomized
coefficient FA was maintained constant for each cell, with a
mean distribution value of 0.8mMs21). In both the experiment
and simulations CPA caused a small reduction in the oscilla-
tory amplitude, while a regular waveform was maintained
throughout the simulated intervention (figure 10). A compari-
son between the experimental and simulated time series is
shown in figures 11a,b. Note that the oscillatory amplitude of
a SMC weakly coupled to its neighbours is reduced, when
compared with the same cell under strongly coupled con-
ditions (figure 11a(ii)(iii)). This effect of weak cell–cell
coupling is greatly enhanced in the case of force development,
as seen in figure 11b. This is due to the fact that the force con-
tributions of individual cells remain largely uncoordinated.
Global force development is restored under strong intercellular
coupling conditions (figure 11b(iii)).4.2.3. Ryanodine intervention
Ryanodine was administrated at the arterial sample at concen-
trations of 10 and 30mM.As discussed previously, the action of
ryanodine can be simulated in different ways depending on the
concentration [22,23]. This is due to the complex multistage
configuration of the ryanodine receptor tetramer. For the
concentrations of ryanodine used in this study, it is accepted
that the compound will block Ca2þ release from the SR in a
concentration-related fashion. The action of ryanodine
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Figure 10. Time evolution of x and z (cell1) for a simulated CPA intervention for different coupling conditions ((aC, aV) ¼ 0.1 s21 and (aC, aV) ¼ 1.0 s21).
Arrows show the intervention time.
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the coefficient CRy at t ¼ 100 s from 1250mMs21 down to
312.5mMs21. The temporal evolution of variables x and zwithin the reference cell1 is shown in figure 12 for different
cellular coupling conditions ((aC, aV) ¼ 0.1 s21 and (aC,
aV) ¼ 1.0 s21). Gradual attenuation of Ca2þ release via
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in frequency.
The forces obtained from the model are compared against
the experimental values in figure 13a,b. In this case, coeffi-
cient u was equal to 0.5. The pattern of the forces follows
Ca2þ concentrations, with the same gradual decreasing mag-
nitude. To simulate this aspect of the experimental traces, weneeded to employ the term in equation (2.1) associated with
store-operated Ca2þ entry, which is triggered in response to
levels of SR Ca2þ. Note that this mechanism only had a
minor effect in the simulation of the phenylephrine and
CPA responses. Similar to the CPA simulations, weakly
coupled SMCs remain uncoordinated in the presence of ryano-
dine, producing weak global contractile force (figure 13b).
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coupling is maintained.5. Discussion
We have developed a multi-component mathematical model-
ling framework that accounts for the structural response of
the arterial wall under the active contraction of the media
smooth muscle layer. The methodology was validated against
a set of pharmacological interventions that modulate the
contractile apparatus at the cellular level. The multiscale mod-
elling approach combines dynamics and mechanics occurring
at different levels, each requiring a specific solution strategy.
With regard to the mechano-elastic component, the study
was performed under isometric conditions, and thus the iner-
tial force is neglected, allowing us to deal with a simplified
system in which the evaluation of a number of dynamic par-
ameters (such as density) was not necessary. Moreover, the
ability to choose a finite-element discretization that conforms
to the cellular grid, eliminated the need for spatial and
temporal interpolation between the two subsystems. As a con-
sequence, it was possible to adopt the same time step for all
elements of the model. This is not a limitation, as different
integration steps can be selected for eachmodel level if required
by the specific problem. This strategy can be implemen-
ted in conjunction with interpolation techniques that allow
information transmission between the various contributing
systems. Although necessary in many cases, this approach
can result in loss of accuracy. All experiments in this study
were performed following administration of L-NAME to elim-
inate the inhibitory effect of endothelium-derived nitric oxide
on the smooth muscle contractile apparatus [36]. Theinvolvement of secondary endothelium produced electro-
chemical factors in the contractile activity of the arterial wall
has not been included, and should form the basis for further
elaboration of the current model [37]. Several arterial ring
experiments under isometric conditions have been carried
out, each involving four rings  2mm in length excised
from the same animal. In spite of efforts to maintain identical
conditions, variability was present, particularly between indi-
vidual animals. With respect to the four arterial rings from
the same arterial sample (e.g. figure 9), experimental and bio-
logical variability that could not be eliminated was due to
differences in length, diameter (all rings were from adjacent
sections, but there is, inevitably, a reduction in diameter as
you descend the vessel), and purely initial condition consider-
ations, such as Ca2þ and ionic uptake levels, which have been
shown both theoretically and experimentally to greatly affect
the oscillatory response of the arterial wall [22,23,30]. Owing
to these factors, each arterial ring is at a different initial contrac-
tile state, reflected in variable unloaded geometry.We therefore
elected to normalize the force traces against the pre-interven-
tion steady state (e.g. the pre phenylephrine force in figure 9)
which would allow us to reproduce the percentile contractile
response during pharmacological probing. This approach
successfully facilitated the main focus of this work which
was the integration of the smooth muscle-based contractile
apparatus and the mechano-elastic properties of the arterial
wall. To investigate this fundamental interaction in the genesis
of arterial tone, we have employed a series of experimental
studies that probe distinct aspects of these mechanisms [22,23].
By simulating experimental findings with the vasoconstrictor
phenylephrine, we were able to match the response time of
the drug, and demonstrate the direct link between cellular
Ca2þ dynamics and the development of force at the tissue
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the global tissue contraction. This finding is correlated to the
increased cytosolic Ca2þ concentrations associated with the
administration of phenylephrine. This observation highlights
the central role of cytosolic Ca2þ influx in the generation of vas-
cular tone and the onset of oscillatory activity observed in both
experiments and simulations. Indeed, we have previously
shown that the levels of Ca2þ influx can modulate other
ionic signalling pathways in a specific, clinically relevant
manner [22]. As noted earlier, phenylephrine mediates Ca2þ
release through the IP3R channel pathway.We have previously
employed different approaches to account for this effect.
In [22], we have considered two independent CICR andInsP3-induced Ca2þ (IICR) release pathways and assumed
that the IICR results in a constant Ca2þ release current, which
is essentially lumped in the overall Ca2þ uptake by the cell.
Both effects are therefore accounted for by the same constant
FA. We have shown that such an assumption still allowed
themathematicalmodel of vasomotion to accurately reproduce
an extensive range of pharmacological interventions [22].
Further work to distinguish the CICR from the IICR mechan-
ism reproduced the same results with no increased accuracy.
We have therefore assumed here the simplified scenario pro-
posed in [22]. The potential of Ca2þ influx to determine the
natural frequency of the cell’s contractile apparatus was the
main reason that parameterFAwas selected for randomization
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dynamics are considerably less sensitive to variations of
other system parameters, associated with alternative ionic
fluxes [29]. Blockage of the SERCA pump with CPA resulted
in a modest pattern variation that highlights the robustness
of the store-refilling mechanism. The resilience of Ca2þ
dynamics under CPA was reproduced by the simulations. A
noteworthy aspect of the function of CPA is its ability to trans-
form arterial vasomotion in a controlled manner that follows
hallmark transition routes out of chaotic behaviour [35,38].
Evidence of this behaviour is shown in figure 11a,b although
detailed investigation of nonlinear oscillatory transitions was
not an aim of this work. Ryanodine receptor dysregulation
is implicated in a range of neuromuscular disorders and
arrhythmogenesis in cardiovascular diseases [3]. This is
mainly due to the complex inter- and intra-subunit interactions
within the ryanodine receptor homotetramer [4,5]. Consider-
ing the intricate multistage dynamics of the ryanodine
channel, computational simulation work can elucidate some
of the dominant components of the mechanism. Althoughstudied here in isolation, dysregulation of the ryanodine
channel has been associated with upregulation of the SERCA
pump protein, to allow for the maintenance of a level of
sustainable homeostasis [39,40]. Such findings support the pro-
posed methodology as a testing ground for hypotheses on the
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